Roche Holding AG (FRA:RHO5)
Germany · Delayed Price · Currency is EUR 356.25
-0.60 (-0.17%)
Inactive · Last trade price on Mar 16, 2026
Roche Holding AG Income Statement
Financials in millions CHF. Fiscal year is January - December.
Millions CHF. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 61,516 | 60,495 | 58,716 | 63,281 | 65,850 |
Other Revenue | 1,840 | 1,900 | 1,725 | 2,533 | - |
Revenue | 63,356 | 62,395 | 60,441 | 65,814 | 65,850 |
Revenue Growth | 1.54% | 3.23% | -8.16% | -0.06% | 9.13% |
Cost of Revenue | 16,162 | 15,731 | 15,597 | 17,938 | 19,360 |
Gross Profit | 47,194 | 46,664 | 44,844 | 47,876 | 46,490 |
Selling, General & Admin | 13,767 | 13,674 | 13,486 | 13,691 | 11,977 |
Research & Development | 12,535 | 13,372 | 13,545 | 13,599 | 14,022 |
Other Operating Expenses | -66 | 1 | 34 | 17 | 238 |
Operating Expenses | 26,236 | 27,047 | 27,065 | 27,307 | 26,237 |
Operating Income | 20,958 | 19,617 | 17,779 | 20,569 | 20,253 |
Interest Expense | -1,187 | -1,248 | -828 | -608 | -342 |
Interest & Investment Income | 203 | 260 | 195 | 40 | - |
Earnings From Equity Investments | -30 | -45 | -32 | -41 | -2 |
Currency Exchange Gain (Loss) | -273 | -291 | -243 | -278 | -232 |
Other Non Operating Income (Expenses) | 5 | -20 | -14 | -90 | 5 |
EBT Excluding Unusual Items | 19,676 | 18,273 | 16,857 | 19,592 | 19,682 |
Merger & Restructuring Charges | -2,185 | -1,934 | -2,063 | -931 | -1,419 |
Impairment of Goodwill | -40 | -3,209 | -591 | - | - |
Gain (Loss) on Sale of Investments | -14 | 35 | 5 | -85 | -89 |
Gain (Loss) on Sale of Assets | 141 | 384 | 569 | 618 | - |
Asset Writedown | -390 | -1,474 | -637 | -2,869 | -634 |
Legal Settlements | -177 | -83 | 172 | 45 | -122 |
Other Unusual Items | -38 | -199 | -233 | -43 | -20 |
Pretax Income | 16,973 | 11,793 | 14,079 | 16,327 | 17,398 |
Income Tax Expense | 3,174 | 2,606 | 1,721 | 2,796 | 2,463 |
Earnings From Continuing Operations | 13,799 | 9,187 | 12,358 | 13,531 | 14,935 |
Minority Interest in Earnings | -919 | -910 | -860 | -1,110 | -1,005 |
Net Income | 12,880 | 8,277 | 11,498 | 12,421 | 13,930 |
Net Income to Common | 12,880 | 8,277 | 11,498 | 12,421 | 13,930 |
Net Income Growth | 55.61% | -28.01% | -7.43% | -10.83% | -2.55% |
Shares Outstanding (Basic) | 796 | 797 | 799 | 800 | 850 |
Shares Outstanding (Diluted) | 803 | 802 | 804 | 808 | 860 |
Shares Change | 0.13% | -0.25% | -0.50% | -6.05% | -0.58% |
EPS (Basic) | 16.18 | 10.39 | 14.39 | 15.53 | 16.39 |
EPS (Diluted) | 16.04 | 10.31 | 14.31 | 15.37 | 16.20 |
EPS Growth | 55.58% | -27.95% | -6.90% | -5.10% | -1.99% |
Additional Metrics
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 15,104 | 16,565 | 12,353 | 14,354 | 17,283 |
Free Cash Flow Per Share | 18.81 | 20.66 | 15.36 | 17.77 | 20.10 |
Dividend Per Share | 9.800 | 9.700 | 9.600 | 9.500 | 9.300 |
Dividend Growth | 1.03% | 1.04% | 1.05% | 2.15% | 2.20% |
Gross Margin | 74.49% | 74.79% | 74.19% | 72.74% | 70.60% |
Operating Margin | 33.08% | 31.44% | 29.42% | 31.25% | 30.76% |
Profit Margin | 20.33% | 13.26% | 19.02% | 18.87% | 21.15% |
Free Cash Flow Margin | 23.84% | 26.55% | 20.44% | 21.81% | 26.25% |
EBITDA | 24,044 | 22,717 | 20,918 | 24,072 | 24,333 |
EBITDA Margin | 37.95% | 36.41% | 34.61% | 36.58% | 36.95% |
D&A For EBITDA | 3,086 | 3,100 | 3,139 | 3,503 | 4,080 |
EBIT | 20,958 | 19,617 | 17,779 | 20,569 | 20,253 |
EBIT Margin | 33.08% | 31.44% | 29.42% | 31.25% | 30.76% |
Effective Tax Rate | 18.70% | 22.10% | 12.22% | 17.13% | 14.16% |
Revenue as Reported | 63,356 | 62,395 | 60,441 | 65,814 | 65,850 |